Sean M. Healey & AMG Center for ALS
Prizes Recognizing Innovation in ALS
The Healey Center offers two prizes for innovation in ALS as global awards celebrating advances in research and care: the Sean M. Healey International Prize for Innovation in ALS, and the Gupta Family Endowed Prize for Innovation in ALS Care.
Sean M. Healey International Prize for Innovation in ALS
The Sean M. Healey International Prize for Innovation in ALS Research recognizes an individual or a team of investigators who catalyze exceptional discoveries leading to a transformative advance in therapy development in ALS.
Established in 2019, Healey Center Director Merit Cudkowicz, MD, MsC said of the award “My vision for the Healey Center International Prize for Innovation is that it will recognize forward-thinking innovators to join the cause and find the cure."
Josh Cohen and Justin Klee, 2022 award recipients
We are honored to be recognized alongside leading ALS clinicians and scientists who are at the forefront of improving outcomes for the ALS community who have no time to wait.
Co-CEOs of Amylyx
2022: The team that brought innovation, rapid development, and efficacy in Phase 2 clinical trials that led to the FDA approval of Relyvrio as a new treatment for ALS, The FDA approved Relyvrio in September, after clinical data showed that the medication slowed disease progression, extending the lives of patients by several months. Learn more.
2021: PRO-ACT, the Pooled Resource Open-Access ALS Clinical Trials Database, for building the largest ALS clinical trials dataset ever created. PRO-ACT merges data from existing publicly- and privately-conducted ALS clinical trials to generate an invaluable resource for accelerating discovery in the field of ALS. Learn more.
2019: Timothy Miller, MD, PhD, of Washington University School of Medicine in St. Louis; Don Cleveland, PhD, of the Ludwig Institute at the University of California at San Diego; Richard Smith, MD, of the Center of Neurological Study in La Jolla, California; Toby Ferguson, MD, PhD, for Biogen and Frank Bennett, PhD, for Ionis Pharmaceuticals; for their work creating the first clinical trial of antisense oligonucleotide (ASO) therapy for ALS. Learn more.
Gupta Family Endowed Prize for Innovation in ALS Care
Inaugurated in 2021, Gupta Family Endowed Prize for Innovation in ALS Care is a global prize to honor ground-breaking new approaches that lead to exceptional care for individuals living with amyotrophic lateral sclerosis (ALS)
2022: The team from ALSUntangled, created by Richard Bedlack, M.D, PhD, Professor of Neurology at Duke University and Director of the Duke ALS clinic, for their work in facilitating more informed decisions treatments for ALS. Learn more.
2021: Penn State Health Milton S. Hershey Medical Center ALS Clinic, for pioneering decentralized multidisciplinary ALS care using digital health and targeted remote monitoring technologies. Learn more.
Lalji Family ALS Award
In 2021, Drs. Shelena and Ayeez Lalji established an award to recognize an individual or team of investigators for excellence in their transformative scientific discoveries focused on repair of neurological function in ALS.
2022: The Answer ALS Team and the team responsible for identifying Stathmin-2 as a therapeutic target for ALS. Learn more.
2021: Marc Freeman, PhD and Michael Coleman, PhD, for their excellence in transformative scientific discoveries focused on repair of neurological function in ALS. Learn more.